• Our VAD Program’s Recent Innovations

    Some of the recent VAD innovations from the Ventricular Assist Device (VAD) program at the Heart Institute at Cincinnati Children’s Hospital, include:

    In July of 2012, a Berlin EXCOR was placed in a 12 month old boy with restrictive cardiomyopathy. This device implantation was unusual because of its cannula placement, in the left atrium. The child was transplanted without complication and is back at home in Kentucky.

    In September 2012, David L.S. Morales, MD and team implanted the first VAD in a Duchenne muscular dystrophy (DMD) patient in the United States. This patient had a HeartMate II implanted, was discharged to home and is now followed in the VAD / Destination clinic.

    In November of 2012, our program implanted a SynCardia Total Artificial (TAH) Heart into a 19-year-old woman with transplant rejection, making her the first female at a children’s hospital to undergo this procedure. 

    In January of 2013, the Cincinnati Children's Hospital Medical Center SynCardia patient was transferred to the Freedom Driver to prepare for discharge home. Only 30 patients in the US have been discharged home on this device.

    In February of 2013, the first female DMD patient (very rare for disease to affect a female) had a HeartWare device placed. She was discharged and followed in the VAD/Destination clinic and is preparing to go home to Oregon.

    In July of 2013, a 3 year old boy had a Berlin implanted for cardiac failure and subsequently received 5 rounds of chemotherapy successfully. He is now listed for transplant.

    National Reputation and Training 

    Training and Research  (Cincinnati Children’s Center for Mechanical Circulatory Support (MCS) Education and Innovation)

    Our VAD / MCS program is an international training site for the Berlin Excor device. Surgical training and in situ simulations are offered to visiting groups. Recently, our program hosted a training session for surgeons from Brazil and Japan, sharing knowledge from implantation to post-op care and long-term support.

    Cincinnati Children’s is part of many investigational trials for new and existing devices. We are currently part of the Berlin EXCOR post approval study, the SynCardia 50 cc device trial, and we are enrolling consented patient data in a national registry.  We are also part of the Freedom driver Syncardia study and recently enrolled our first patient.